Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response.
Facchini G, D'Arienzo A, Nicastro A, Flauto F, Izzo M, Montella L, Riccardo F, Fusco GM, Trama F, Lauro GD, Costanzo GD, Tucci AG, Iasiello F, Di Lorenzo L, Maddaluno S, Liguori C, Cupillo RAD, Coppola P, Minissale A, Nardo MTD, Formisano L, Martinelli E, Ciappina G, Pisconti S, Berretta M, Barraco C.
Facchini G, et al. Among authors: barraco c.
Cancers (Basel). 2025 Aug 5;17(15):2573. doi: 10.3390/cancers17152573.
Cancers (Basel). 2025.
PMID: 40805269
Free PMC article.